Clinical Trials Directory

Trials / Completed

CompletedNCT02661867

Pelvic Floor Function Evaluation of Singleton Primiparae After Vaginal Delivery and Cesarean Section

Pelvic Floor Function Evaluation of Singleton Primiparae After Vaginal Delivery and Cesarean Section: Seven to Twelve-Year Long Observational Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
865 (actual)
Sponsor
Brno University Hospital · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

Objective of this longitudinal observational cohort study was to analyze incidence of pelvic floor dysfunction (PFD) symptoms, including pelvic organ prolapse (POP), urinary incontinence (UI), and fecal incontinence (FI), seven to twelve years after delivery, in two groups of singleton primiparae after vaginal delivery (VD) and cesarean section (CS).

Detailed description

Pelvic floor disorders (PFD) usually refers to three definable groups of symptoms that include pelvic organ prolapse (POP), urinary incontinence (UI), and fecal incontinence (FI). The prevalence of these conditions increases with age, but in general, PFD affect 20-50 % of women throughout their lives. Thus, PFD are common and have significant societal impact. Another important PFD risk factor is childbearing. Specifically, these disorders are more common among multiparas. Vaginal delivery (VD) has been considered the main contributing factor because of pelvic floor muscle, fascia, and nerves damage.

Conditions

Interventions

TypeNameDescription
BEHAVIORALdeliverydelivery either vaginal or by cesarean section

Timeline

Start date
2002-01-01
Primary completion
2007-12-01
Completion
2014-12-01
First posted
2016-01-25
Last updated
2016-01-25

Source: ClinicalTrials.gov record NCT02661867. Inclusion in this directory is not an endorsement.